Results 11 to 20 of about 2,273 (120)
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial. [PDF]
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Wu L +56 more
europepmc +2 more sources
Abstract Background and Aims Involving patients in research, not only as trial subjects, is not a newly established practice. Over the last two decades, patient roles have gradually expanded to become active research contributors, creating a more patient‐centered research landscape.
Ivana Nohová +5 more
wiley +1 more source
Causes of pregnancy arrest in the canine species
Abstract In the canine species, early pregnancy arrest before 30–40 days of pregnancy will induce intra‐uterine embryonic or foetal resorption, with very few clinical signs. If no genital examination by ultrasound is performed at that time, it will often remain unnoticed and the bitch will be qualified as infertile. It is only when pregnancy stops at a
Alain Fontbonne
wiley +1 more source
Abstract Background The PRIMA/ENGOT‐OV26/GOG‐3012 (NCT02655016) trial was amended to prospectively evaluate the safety and efficacy of an individualized starting dose (ISD) regimen of niraparib for first‐line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Mansoor R. Mirza +20 more
wiley +1 more source
Top advances of the year: Cervical cancer
Abstract Cervical cancer continues to affect women in the United States and throughout the world despite an effective vaccine against human papillomavirus and cancer screening programs. For the women who develop cervical cancer, surgery, radiation, and chemotherapy have been the mainstays of treatment for years.
Sarah E. Podwika, Linda R. Duska
wiley +1 more source
Sinonasal inverted papilloma – malignant transformation and non‐sinonasal malignancies
Objectives To assess malignant transformation rate, non‐sinonasal malignancies, and factors contributing to recurrence in patients treated for sinonasal inverted papilloma (SNIP). Study Design Retrospective study. Methods We retrospectively reviewed medical records of all patients treated for SNIP (n = 296) between the years 1984–2014 at Helsinki ...
Sanna Viitasalo +10 more
wiley +1 more source
ABSTRACT Objective Previous work has suggested that the ultrasound‐based benign simple descriptors (BDs) can reliably exclude malignancy in a large proportion of women presenting with an adnexal mass. This study aimed to validate a modified version of the BDs and to validate a two‐step strategy to estimate the risk of malignancy, in which the modified ...
C. Landolfo +30 more
wiley +1 more source
Abstract The presence of a cloaca in the reproductive tract of marsupials may predispose them to ascending infections. A 7‐year‐old, entire, female sugar glider presented with abdominal swelling. Whole‐body radiographs and abdominal ultrasound revealed a mass in the abdomen.
Tiziana Bassan +4 more
wiley +1 more source
Platyfish bypass the constraint of the caudal fin ventral identity in teleosts
Abstract Background: The caudal fin of teleosts is characterized by dorsoventral symmetry. Despite this external morphology, the principal rays of this appendage connect to bones below the notochord, indicating the ventral (hypochordal) identity of this organ.
Lana Rees +2 more
wiley +1 more source
Efeito da somatotropina bovina recombinante (rbST) na produção in vivo e na maturação in vitro de oócitos bovinos da raça Sindi [PDF]
RESUMO A fim de avaliar o efeito de diferentes doses da rbST sobre a dinâmica folicular, a produção e a maturação in vitro de oócitos, 20 vacas Sindi, divididas em três grupos, receberam um dispositivo de progesterona intravaginal, estradiol e PGF2α ...
L.G.M. Ribeiro +13 more
doaj +2 more sources

